FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site

Nuclear Medicine Communications

Volumn 33, Issue 3, 2012, Pages 305-312

  Jackson, Tatianie ^a   Chung, Margaret K ^a   Mercier, Gustavo ^a   Ozonoff, Al ^a   Subramaniam, Rathan M ^b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

diameter; interobserver agreement; positron emission tomography; standardized uptake value

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOVERSOL;

ADULT; AGED; ARTICLE; CANCER SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CORRELATION COEFFICIENT; DRUG MEGADOSE; FEMALE; HEAD AND NECK CANCER; HUMAN; INTERRATER RELIABILITY; LOW DRUG DOSE; MALE; MEDICAL STUDENT; METABOLIC PARAMETERS; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; RESIDENT; STANDARDIZED UPTAKE VALUE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS;

EID: 84856103634     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834e5397     Document Type: Article

References (20)

1. Jacene HA, Leboulleux S, Baba S, Chatzifotiadis D, Goudarzi B, Teytelbaum O, et al. Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy. J Nucl Med 2009; 50: 1760-1769.
2. Thie JA, Hubner KF, Smith GT. The diagnostic utility of the lognormal behavior of PET standardized uptake values in tumors. J Nucl Med 2000; 41: 1664-1672.
3. Nahmias C, Wahl LM. Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med 2008; 49: 1804-1808.
4. Nakamoto Y, Chang AE, Zasadny KR, Wahl RL. Comparison of attenuationcorrected and non-corrected FDG-PET images for axillary nodal staging in newly diagnosed breast cancer. Mol Imaging Biol 2002; 4: 161-169. (Pubitemid 34272700)
5. Krabbe CA, Pruim J, Dijkstra PU, Roodenburg JL. 18F-FDG PET for routine posttreatment surveillance in oral and oropharyngeal squamous cell carcinoma. J Nucl Med 2010 [Epub ahead of print].
6. Davison JM, Ozonoff A, Imsande HM, Grillone GA, Subramaniam RM. Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake. Radiology 2010; 255: 578-585.
7. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174. (Pubitemid 8054849)
8. Wong WL, Chevretton EB, McGurk M, Hussain K, Davis J, Beaney R, et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol 1997; 22: 209-214. (Pubitemid 28344969)
9. Dammann F, Horger M, Mueller-Berg M, Schlemmer H, Claussen CD, Hoffman J, et al. Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. Am J Roentgenol 2005; 184: 1326-1331. (Pubitemid 43821922)
10. Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, Yonekura Y. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 2003; 30: 63-71. (Pubitemid 36692894)
11. Kresnik E, Mikosch P, Gallowitsch HJ, Kogler D, Heinisch M, Unterweger O, et al. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 2001; 28: 816-821. (Pubitemid 32662543)
12. Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 2005; 46: 1136-1143. (Pubitemid 43741075)
13. Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004; 22: 69-76. (Pubitemid 41095116)
14. Monsky WL, Raptopoulos V, Keogan MT, Doty D, Kamel I, Yam CS, Ransil BJ. Reproducibility of linear tumor measurements using PACS: comparison of caliper method with edge-tracing method. Eur Radiol 2004; 14: 519-525. (Pubitemid 38324929)
15. Wormanns D, Diederich S, Lentschig MG, Winter F, Heindel W, Spiral CT. of pulmonary nodules: interobserver variation in assessment of lesion size. Eur Radiol 2000; 10: 710-713. (Pubitemid 30321077)
16. Erasmus JJ, Gladish GW, Broemeling L, Sabloff BS, Truong MT, He rbst RS, Munden RF. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 2003; 21: 2574-2582. (Pubitemid 46606340)
17. Revel MP, Bissery A, Bienvenu M, Aycard L, Lefort C, Frija G. Are two dimensional CT measurements of small noncalcified pulmonary nodules reliable? Radiology 2004; 231: 453-458. (Pubitemid 38552904)
18. Mukherji SK, Toledano AY, Beldon C, Schmalfuss IM, Cooper JS, Sicks JD, et al. Interobserver reliability of computed tomography-derived primary tumor volume measurement in patients with supraglottic carcinoma. Cancer 2005; 103: 2616-2622. (Pubitemid 40800542)
19. Goodman LR, Gulsun M, Washington L, Nagy PG, Piacsek KL. Inherent variability of CT lung nodule measurements in vivo using semiautomated volumetric measurements. Am J Roentgenol 2006; 186: 989-994. (Pubitemid 46100197)
20. Xie P, Yue JB, Zhao HX, Sun XD, Kong L, Fu Z, Yu JM. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2010; 136: 883-889.